Barrow Neurological Institute is the world's largest neurological disease treatment and research institution, and is consistently ranked as one of the best neurosurgical training centers in the United States. Founded in 1962, the main campus is located at 350 W. Thomas Road, Phoenix, Arizona.

During the past decade, Barrow Tuberous Sclerosis Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Barrow Tuberous Sclerosis Center" are "Lymphangioleiomyomatosis (LAM)" (1 trials), "Subependymal Giant Cell Astrocytoma" (1 trials), "Tuberous Sclerosis" (1 trials) and "Tuberous Sclerosis Complex (TSC)" (1 trials). Many other conditions were trialed in "Barrow Tuberous Sclerosis Center" in a lesser frequency.

Most popular intervention types in "Barrow Tuberous Sclerosis Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Everolimus" (1 trials), "Everolimus (RAD001)" (1 trials), "Everolimus Placebo" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Barrow Tuberous Sclerosis Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Barrow Tuberous Sclerosis Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Barrow Tuberous Sclerosis Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Barrow Tuberous Sclerosis Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".